Pharmacodynamics

Two drugs can have the same blood level but wildly different effects — pharmacodynamics explains what the drug does to the body once it arrives at its target.

Pharmacodynamics is the study of how drugs produce their effects at the cellular level. Drugs act primarily by binding to receptors (proteins on or inside cells). An agonist binds a receptor and activates it, mimicking the body's own chemical signals — albuterol activates beta-2 receptors to relax bronchial smooth muscle. An antagonist binds the receptor but blocks activation — propranolol blocks beta receptors, preventing the heart rate increase that epinephrine would cause. Partial agonists (like buprenorphine) activate receptors but produce a submaximal response, which creates a ceiling effect. Two critical measurable concepts: potency refers to how much drug is needed to produce an effect (lower dose = higher potency), while efficacy refers to the maximum effect a drug can achieve regardless of dose. A drug can be highly potent but have low efficacy, or vice versa. Dose-response relationships follow a predictable curve — the therapeutic effect increases with dose until a plateau, after which more drug adds toxicity without benefit. The therapeutic index (TI) compares the toxic dose to the therapeutic dose; a narrow TI (like digoxin, lithium, warfarin) means the margin between help and harm is slim.

Key Distinctions

Don't confuse pharmacodynamics (drug's effect on the body) with pharmacokinetics (body's effect on the drug — absorption, distribution, metabolism, excretion). Students mix up potency and efficacy: morphine and buprenorphine both act at mu-opioid receptors, but morphine has higher efficacy (greater maximal pain relief) while buprenorphine, a partial agonist, has a ceiling effect. Competitive antagonists can be overcome by increasing agonist concentration; noncompetitive antagonists cannot — this distinction changes clinical management.

Clinical Pearl

Potency picks the dose; efficacy picks the drug. A narrow therapeutic index means you're walking a tightrope — small dose changes can tip the patient from treatment into toxicity.